'Everything Wrong With the Offshore Ebola Quarantine Plan'

 The U.S. is erecting a make-shift field hospital at the Laikipia Air Base in Central Kenya to quarantine, monitor, and treat U.S. citizens exposed to Bundibugyo ebolavirus. Built by the military and staffed by U.S. Public Health Service (PHS) personnel, the facility is intended to bypass the longstanding practice of medical evacuations to specialized U.S. hospitals. While it was originally set to open this week, a Kenyan court temporary blocked the plan pending further hearings. In its court petition, rights' group the Katiba Institute warned that the arrangement posed "grave and imminent risks" to public health.

This offshore containment strategy comes on the heels of government directives that bar non-citizens from entering the U.S. if they have traveled to the outbreak zone in the past 21 days. The administration has drawn an absolute line at the border. As Secretary of State Marco Rubio bluntly put it: "We cannot and will not allow any cases of Ebola to enter the United States."

While administration officials frame this as defending our borders and ensuring "rapid access to care" for exposed individuals, the medical, ethical, and legal reality is far more troubling. Most importantly, the Kenya plan will put American lives at risk, trading proven clinical and public health standards for political theater.

Clinical Risks: Swapping Biocontainment for Makeshift Medicine

The most immediate concern is clinical. Ebola is a complex and lethal disease requiring resource-intensive, critical care. During previous outbreaks, the U.S. successfully evacuated and treated infected Americans at specialized, state-of-the-art biocontainment units like those at Emory University Hospital in Atlanta and the University of Nebraska Medical Center. These hospitals possess decades of institutional knowledge, rigid safety infrastructure, and immediate access to advanced life-support systems. That world-class care directly saved lives.

Replacing specialized domestic hospitals with a hastily erected facility at a Kenyan air base risks American lives. The Bundibugyo is a rare virus strain for which there are currently no approved vaccines or targeted therapeutic treatments. Managing it relies on high-level supportive care. Administration officials say that Americans who become ill and require advanced care will be transported to Europe for treatment, but no countries or facilities have been identified.

Meanwhile, expecting PHS personnel -- many of whom are being deployed rapidly into a fluid environment -- to maintain rigid Level 4 biocontainment protocols in a temporary field hospital is unrealistic. The risk of occupational exposure for frontline staff is unacceptably high. If an infection control breach occurs, PHS staff could be exposed to a highly pathogenic virus. The administration is compromising patient outcomes and workforce safety to keep the virus physically off U.S. soil.

An Ethical Failure: The "Duty to Care"

The rapid construction of the Laikipia facility is being driven by a multi-agency scramble involving the State and Defense Departments and HHS. Millions of taxpayer dollars are being funneled into erecting a temporary biometric and isolation station in Africa. These resources would be far better spent reinforcing public health capacities in the Democratic Republic of Congo (DRC) and other affected countries.

Furthermore, the U.S. government owes an ethical duty of care to citizens who have been exposed to ebolavirus. Many exposed individuals will be those who have volunteered to provide clinical care and humanitarian relief in a conflict zone -- like Peter Stafford, MD, the medical missionary in the DRC who was the first (and so far, the only known) American to contract Ebola during this outbreak. By telling these individuals they will be barred from returning home if they are exposed, the government is placing them at undue risk.

No administration -- Republican or Democratic -- has funneled citizens to facilities abroad instead of safely evacuating them to America. While countries, like Germany for Stafford, have volunteered to provide specialized care to exposed U.S. citizens, this is not the standard strategy.

The U.S. Response is Counterproductive

Public health experts have warned that this strategy is entirely self-defeating. When you tell people they will be forcibly marooned in an offshore facility, you create a powerful disincentive for transparent reporting.

Exposed individuals may hide their symptoms and delay seeing diagnoses and care. High-risk individuals might attempt to bypass formal screening channels entirely to sneak home. This could drive the virus underground, accelerating the exact domestic threat the administration claims it is trying to prevent. These measures will also discourage health and humanitarian workers from traveling to the region to assist with the response, exacerbating the risk of continuing spread.

The Constitutional and Legal Morass

Legally, the Laikipia plan walks a dangerous constitutional tightrope. While the government possesses broad quarantine powers under the Public Health Service Act, the right of American citizens to return to their home country is a core tenet of international human rights law and domestic constitutional law.

The Trump administration stated that citizens will not be allowed to return until they are "cleared from quarantine." By leveraging the military to hold citizens on a foreign air base, the administration is functionally enacting an external, extraterritorial ban on its own population. It subverts due process by using geographic exclusion to strip citizens of their right of return. Forcibly detaining a citizen in Kenya under the guise of biosecurity is a gross violation of civil liberties.

Geopolitical Blowback and Ruptured Trust

Finally, the geopolitical optics are ugly. The establishment of this facility communicates a deeply cynical message to our African partners: the U.S. views the continent not as a partner to be supported, but as a dangerous buffer zone to absorb American bio-risk.

The Kenyan government's initial hesitation -- and its subsequent demand that the facility be open to all nationalities rather than acting as an exclusive, segregated enclave for Americans -- underscores the diplomatic friction. And now, the future of the facility hangs in the balance pending the Kenyan court's ultimate decision. The response from Kenya clearly demonstrates the rancor and distrust the Trump administration has caused.

All of this comes on the heels of severe U.S. foreign aid cuts that dismantled early-defense health infrastructure in the DRC; these latest actions signal a further retreat from global health leadership. The U.S. is no longer exporting solutions; we are exporting our panic.

The Laikipia quarantine facility is a symptom of a broader, isolationist approach to global health security. Pandemics cannot be stopped by harsh and restrictive measures. Epidemic preparedness requires robust domestic containment, transparent reporting, health equity, and a commitment to clinical and scientific excellence.

Lawrence O. Gostin, JD, LLD (Hon), is Distinguished University Professor, Georgetown University’s highest academic rank, and Founding O’Neill Chair in Global Health Law. He directs the World Health Organization Center on National and Global Health Law, and serves on high-level WHO expert committees. A member of the National Academy of Medicine, he was awarded the Distinguished Lifetime Achievement Award in 2006. President Obama appointed Gostin to a 6-year term on the President’s National Cancer Advisory Board in 2016. The National Consumer Council (U.K.) bestowed upon him the Rosemary Delbridge Memorial Award in 1986 for the person “who has most influenced Parliament and government to act for the welfare of society.” His MedPage Today column, “The Health Docket,” offers insights into the state of domestic and global health law.

https://www.medpagetoday.com/opinion/the-health-docket/121493